Publications

Publications

Westat researchers publish on a wide array of topics that further our understanding of the field and focus on improving lives through research. Selected publications that communicate our findings, including books, peer-reviewed articles and technical reports, conference proceedings, and more are presented here.

2022

Friesen M.C., Hung F., Xie S., Viet S.M., Deziel N.C., Locke S.J., Josse P.R., Sauvé J.F., Andreotti G., Thorne P.S., Beane-Freeman L.E., and Hofmann J.N. (2022).

A task-specific algorithm to estimate occupational (1→3)-ß-D-glucan exposure for farmers in the Biomarkers of Exposure and Effect in Agriculture Study.

Ren W., Li J., Erciulescu A.L., Krenzke T., and Mohadjer L. (2022).

A variable selection method for small area estimation modeling of the proficiency of adult competency.

Miller M.J., Himschoot A., Fitch N., Jawalkar S., Freeman D., Hilton C., Berney K., Guy G.P., Benoit T.J., Clarke K.E.N., Busch M.P., Opsomer J.D., Stramer S.L., Hall A.J., Gundlapalli A.V., MacNeil A., McCord R., Sunshine G., Howard-Williams M., Dunphy C., and Jones J.M. (2022).

Association of trends in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) seroprevalence and state-issued nonpharmaceutical interventions: United States, 1 August 2020 to 30 March 2021.

Busch M.P., Stramer S.L., Stone M., Yu E.A., Grebe E., Notari E., Saa P., Ferg R., Molina Manrique I., Weil N., Fink R.V., Levy M.E., Green V., Cyrus S., Williamson P.C., Haynes J., Groves J., Krysztof D., Custer B., Kleinman S., Biggerstaff B.J., Opsomer J.D., and Jones J.M. (2022).

Population-weighted seroprevalence from Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection, vaccination, and hybrid immunity among US blood donations from January to December 2021.

Campione J.R., Ritchie N.D., Fishbein H.A., Mardon R.E., Johnson M.C., Pace W., Birch R.J., Seeholzer E.L., Zhang X., Proia K., Siegel K.R., and McKeever Bullard K. (2022).

Use and impact of type 2 diabetes prevention interventions.

Link-Gelles R., Levy M.E., Gaglani M., Irving S.A., Stockwell M., Dascomb K., DeSilva M.B., Reese S.E., Liao I.-C., Ong T.C., Grannis S.J., McEvoy C., Patel P., Klein N.P., Hartmann E., Stenehjem E., Natarajan K., Naleway A.L., Murthy K., Rao S., Dixon B.E., Kharbanda A.B., Akinseye A., Dickerson M., Lewis N., Grisel N., Han J., Barron M.A., Fadel W.F., Dunne M.M., Goddard K., Arndorfer J., Konatham D., Valvi N.R., Currey J.C., Fireman B., Raiyani C., Zerbo O., Sloan-Aagard C., Ball S.W., Thompson M.G., and Tenforde M.W. (2022).

Effectiveness of 2, 3, and 4 COVID-19 mRNA vaccine doses among immunocompetent adults during periods when SARS-CoV-2 omicron BA.1 and BA.2/BA.2.12.1 sublineages predominated — VISION Network, 10 States, December 2021–June 2022.

Slotman B.A., Stinchcomb D.G., Powell-Wiley T.M., Ostendorf D.M., Saelens B.E., Gorin A.A., Zenk S.N., and Berrigan D. (2022).

Environmental data and methods from the Accumulating Data to Optimally Predict Obesity Treatment (ADOPT) core measures environmental working group.

Bond G.R., Al-Abdulmunem M., Ressler D.R., Gade D.M., and Drake R.E. (2022).

A randomized controlled trial of an employment program for veterans transitioning from the military: Two-year outcomes.

Caminiti C., Bryce J., Riva S., Ng D., Diodati F., Iezzi E., Sparavigna L., Novello S., Porta C., Del Mastro L., Procopio G., Cinieri S., Falzetta A., Calabrò F., Lorusso V., Cogoni A.A., Tortora G., Maruzzo M., Passalacqua R., Cognetti F., Adamo V., Capelletto E., Ferrari A., Bagnalasta M., Bassi M., Nicelli A., De Persis D., D'Acunti A., Iannelli E., Perrone F., and Mitchell S.A. (2022).

Cultural adaptation of the Italian version of the Patient-Reported Outcomes Common Terminology Criteria for Adverse Event (PRO-CTCAE).

Brick J.M., Andrews W.R., and Foster J. (2022).

A review of nonprobability sampling using mobile apps for fishing effort and catch surveys.

Want to work with us?
You’ll be in great company.

About Us Careers

Westat Employees.
Westat Employee.
AAA Foundation for Traffic Safety
Baltimore Metropolitan Council
Centers for Disease Control and Prevention
Centers for Medicare & Medicaid Services
Chicago Metropolitan Agency for Planning
DC Public Schools
Georgia Department of Transportation
Internal Revenue Service
Leadership Montgomery
Maryland Cancer Registry
Michigan Department of Health and Human Services
National Science Foundation
NYC Mayor’s Office for Economic Opportunity
Organization for Economic Cooperation and Development
Robert Wood Johnson Foundation
SiriusXM
Social Security Administration
Substance Abuse and Mental Health Services Administration
Teach for America
Texas Education Agency
The Johns Hopkins University
The National Institutes of Health
The Verizon Foundation
Toyota
U.S. Department of Agriculture
U.S. Department of Education
U.S. Department of Health and Human Services
U.S. Department of Justice
U.S. Department of Transportation
U.S. Department of Veterans Affairs
University of Maryland Baltimore Campus
University of Michigan
University System of Maryland
Explore Our Clients

Please wait...

Forbes 2022 The Best Employers for Women Powered by Statista Forbes 2021 The Best Employers for Veterans Powered by Statista

Westat is an Equal Opportunity Employer and does not discriminate on the basis of race, creed, color, religion, sex, national origin, age, veteran status, disability, marital status, sexual orientation, citizenship status, genetic information, gender identity or expression, or any other protected status under applicable law. Notices to Employees & Applicants.